Compare FedEx Corporation (FDX) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs Hims and Hers Health Inc — how do they compare? FedEx Corporation trades at $292.44 (market cap $69.04B), while Hims and Hers Health Inc trades at $28.47 (market cap $6.55B). The key difference: FedEx Corporation is far larger — about 10.5× Hims and Hers Health Inc's market cap, and FedEx Corporation pays a 1.67% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Hims and Hers Health Inc for 21 Days on average.
| FDX | HIMS | |
|---|---|---|
Market Cap | $69.04B | $6.55B |
Volume | 1,287,367 | 14,842,814 |
Sector | Industrials | Health |
52-Week High | $339.35 | $62.76 |
52-Week Low | $180.87 | $14.52 |
Typical Hold Time | 87 Days | 21 Days |
Enterprise Value | $98.68B | $7.25B |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FDX trades at $289.04, flat on the day, with a bearish technical signal from moving averages and ADX indicators. The company reported revenue of $87.93B for 2025, with a net income margin of 4.68% and a P/E ratio of 15.58. Recent news includes a $300 million order for electric trucks from Harbinger and shareholder approval of executive compensation at the annual meeting.
The outlook is mixed, with strong analyst buy consensus (57%) and a price target of $307.55 offering upside potential, but risks from rising fuel costs and a bearish technical trend suggest near-term volatility. Earnings beats in recent quarters support fundamental strength, yet macroeconomic pressures on logistics margins warrant caution.
Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.
The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
